Featured Articles
-
A New Mindset For Combination Product Development
6/15/2022
As we balance the time-to-market and risk for novel therapies, we must anticipate changing needs for combination device development, highlighting the technological paradigm shift.
-
Sustainability Considerations For Drug Delivery Device End-To-End Solutions
6/15/2022
Learn how to address the gradual unlinking of economic activity from the consumption of finite resources and the removal of waste to support and help prevent a global climate catastrophe.
-
Accelerating Novel Therapies To The Market
6/15/2022
The formulations for novel therapeutics require flexibility to support adaptive sterile manufacturing and an integrated approach for a path from development, to small batch manufacturing, to commercialization.
-
Computational Modeling Of Injection-Related Tissue Responses
6/15/2022
Optimizing delivery along with the formulation is the key to successful clinical outcomes. Research is necessary to understand the relationship between body morphology, injection force, and needle length.
-
High Viscosity Formulations: Developing A 'Human Solution' To Autoinjector Design
3/2/2022
Delivering high viscosity (HV) formulations with a truly human solution involves a balance between safety and practicality. Learn the importance of achieving this solution with HV autoinjector design.
-
Characterization & Delivery Of Ultra-Viscous & Non-Newtonian Formulations
3/2/2022
Discover how to identify characteristics at the earliest stage, a vital step in autoinjector device platform development, with the use of the innovative Injection Characterization System (ICS).
-
Patient-Centricity: The Importance Of Human Factors In The Pandemic Era
6/4/2021
Discover how patient-centricity is at the heart of drug delivery device design and innovation and how the global pandemic has highlighted the importance of patient-centric development in this field.
-
Integrating Design And Industrialization To Optimize Cost, Quality & Time
6/1/2021
Explore how integrating design and industrialization teams can optimize the cost, quality, and time of developing a novel drug delivery system.
-
Meeting The Challenge Of Delivering High-Volume Biologic Therapies
2/16/2021
As the industry moves toward self-administration to reduce healthcare costs and improve patient convenience, there is a compelling need for simple-to-use, low-cost, disposable devices.
-
High Viscosity Formulations: Developing An Effective Primary Drug Container System
2/10/2021
The past few years have seen a significant increase in the number of high viscosity (HV) formulations (100 – 1000 cP) being developed. There are a number of steps that autoinjector developers can take to meet the challenges posed by such formulations. This white paper focuses on some of the techniques used to develop the ArQ™-Bios high viscosity platform.